Global HIV News
Hepatitis 03/05/2012
Transgene reports positive follow up Phase 2 data on its HCV therapeutic vaccine TG4040
Both faster efect on viral load decrease and significant improvement of viral response over time (week 24) in TG4040 pre-vaccination arm.
World Policy 03/05/2012
Greece arrests 17 HIV-positive women in brothel crackdown
"This is an appalling violation of human rights and medical confidentiality."
Basic Science 03/05/2012
Genetically modified T cell therapy shown to be safe, lasting in decade-long Penn medicine study of HIV patients
Results open up field of T cell gene therapy for use in other diseases.
Treatment 03/05/2012
Only 1 in 5 people living with HIV fully engaged in care in U.S. study
The results underscore a need for improvements in keeping those living with the virus connected to care.
Prevention 03/05/2012
Leading AIDS advocates support FDA approval of pre-exposure prophylaxis (PrEP), a promising new HIV prevention method, for men and women
A group of 14 leading HIV/AIDS and health organizations states their support for FDA approval of Truvada as PrEP to prevent HIV infection in adult men and women.
World Policy 03/05/2012
Full agenda for WHO: Reform, R&D convention, substandard medicines, NCDs, pandemics
In preparation for the 65th annual World Health Assembly country delegations are in the process of solidifying national and regional positions on a wide range of essential public health issues.
Treatment 01/05/2012
Anti-HIV drug use during pregnancy does not affect infant size, birth weight
NIH study indicates drug safe during pregnancy, but infants smaller at first birthday.
World Policy 01/05/2012
East Africa: Regional HIV Bill passed without criminalization clause
East Africa's Legislative Assembly has passed a regional HIV/AIDS Bill that seeks to protect the rights of people living with HIV and harmonize regional legislation and policy on the prevention and treatment of HIV.
World Policy 01/05/2012
WHO HIV drug resistance program detailed in online journal issue
The World Health Organization (WHO) HIV Drug Resistance Prevention and Assessment Strategy is the sole topic of a large May 2012 supplement to the journal Clinical Infectious Diseases.
Treatment 01/05/2012
HIV RNA control tied to low HIV DNA in perinatally infected youth
Undetectable HIV RNA in plasma was associated with low HIV DNA in blood cells in a study of 15- to 24-year-olds in France who had been infected since infancy.
Hepatitis 01/05/2012
J&J open to expanding hepatitis C cooperation with Vertex
J&J may explore widening cooperation on hepatitis C with Vertex that may develop in tandem with a separate partnership with Medivir on the disease.
Hepatitis 01/05/2012
Achillion clarifies end of treatment data from Phase 2a trial with ACH-1625 based regimen in hepatitis C
ACH-1625 is a Phase 2 pan-genotypic HCV protease inhibitor.
Treatment 01/05/2012
FDA: New pediatric Lexiva dosing regimen for patients from at least 4 weeks to less than 6 years of age
FDA approved dosing recommendations for use of Lexiva oral suspension in pediatric patients.
World Policy 01/05/2012
UN Secretary-General issues recommendations to bolster AIDS response in order to meet 2015 targets
In his report to the UN General Assembly, UN Secretary-General Ban Ki-moon urges stakeholders to redouble efforts to meet the targets outlined in the 2011 Political Declaration on AIDS.
Treatment 01/05/2012
Reductions in visceral fat during tesamorelin therapy associated with improvements in key metabolic markers
Reductions in visceral adipose tissue during tesamorelin therapy are associated with improvements in triglyceride levels, adiponectin levels, and long-term preservation of glucose homeostasis.
Tuberculosis & Malaria 28/04/2012
Aeras and TBVI agree to strengthen collaboration on advancing new TB vaccines
The collaboration between Aeras and TBVI will address significant scientific opportunities and challenges described in Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade.
World Policy 28/04/2012
New report finds that the US Government is the largest funder of global health R&D worldwide
Investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world.
Access to treatment 28/04/2012
Will India continue to supply cheap drugs?
Millions will die if India cannot produce the new HIV/AIDS medicines in the future –it is a matter of life and death.
Tuberculosis & Malaria 28/04/2012
Ranbaxy launches homegrown malaria drug
India's first new chemical entity developed through clinical trials and commercialization in India.
Tuberculosis & Malaria 28/04/2012
Ahead of World Malaria Day, WHO heralds gains against disease, calls for greater treatment coverage
WHO's new initiative, T3: Test. Treat. Track., urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build robust malaria surveillance systems.
More...
